Snoop 0.05 instructions for use for children. Snoop - instructions for use

The alpha-agonist used in otorhinolaryngology is Snoop. Instructions for use indicate that nasal spray 0.05% and 0.1%, aerosol, nasal drops have a vasoconstrictive effect. Reviews of otolaryngologists explain that the medicine helps in the treatment of rhinitis, sinusitis, pollinosis.

Release form and composition

Spray Snoop is available as a clear, colorless liquid. The main active ingredient of the drug is xylometazoline hydrochloride, its content in 1 ml of spray can be 500 mcg (0.05% solution) and 1 mg (0.1% solution). Also, the composition of the solution includes additional components, which include:

Potassium dihydrogen phosphate.
Sea water.
The water is purified.

The Snoop spray solution is in a 15 ml polyethylene (plastic) bottle with a spray valve (150 doses). The cardboard pack contains one bottle of nasal spray and instructions for use.

pharmachologic effect

Snoop is a local vasoconstrictor with alpha-adrenomimetic activity. Xylometazoline contributes to the narrowing of the blood vessels of the nasal mucosa, relieves swelling and eliminates hyperemia of the nasal mucosa, which leads to a rapid relief of nasal breathing. The patency of the nasal passages is restored a few minutes after the use of the drug.

Sea water tends to improve the function of the ciliated epithelium and normalize the production of mucus in the goblet cells of the nasal mucosa. Its presence in the composition of the drug helps to maintain the natural physiological state of the nasal cavity. The duration of action of the drug is several hours.

Indications for use

What helps Snoop? The spray is actively used in ENT practice to relieve negative symptoms with:

acute respiratory infections with symptoms of rhinitis;
allergic rhinitis (acute form);
sinusitis;
eustachitis;
otitis media (to reduce swelling in the composition combination therapy);
hay fever.

The drug can be prescribed before such a diagnostic manipulation as rhinoscopy, to facilitate the procedure, improve the patency of the nasal passages.

Instructions for use

Snoop for children aged 2 to 6 years is prescribed 1 injection of nasal spray 0.05% in each nostril (if necessary, can be repeated) up to 3 times a day.

Adults and children over 6 years of age are prescribed 1 injection of Snoop nasal spray 0.1% in each nostril (if necessary, can be repeated) up to 3 times a day. The drug should not be used more than 3 times a day. The duration of the course of treatment is no more than 5-7 days.

Contraindications

arterial hypertension;
carrying a pregnancy;
atrophic rhinitis;
individual hypersensitivity;
glaucoma;
severe atherosclerosis;
cardiopalmus;
thyrotoxicosis;
a history of specialized surgical interventions on the meninges of the brain;

A solution of 0.1% is not used in pediatric practice in children under 6 years old, 0.05% - up to 2 years.

Relative contraindications (use with caution):

breast-feeding;
angina pectoris (ischemia of the heart muscle);
diabetes;
prostate hyperplasia.

Side effects

Against the background of the use of Snoop nasal spray, the development of pathological adverse reactions from various systems is possible:

Cardiovascular system - the appearance of a feeling of palpitations, an increase in heart contractions (tachycardia) or a violation of their rhythm (arrhythmia), an increase in the level of systemic arterial pressure (arterial hypertension).
Digestive system - vomiting rarely develops.
Nervous system - a headache can rarely occur, insomnia can develop, various visual impairments, a prolonged and pronounced deterioration in mood (depression) against the background of high doses of the drug.
Respiratory system - irritation, dryness of the nasal mucosa, accompanied by burning, sneezing, increased secretion of mucus, less often swelling of the nasal mucosa develops.

Almost all pathological negative reactions are dose-dependent. When they appear, the dosage of the drug should be reduced. If this does not lead to the disappearance of side effects, then the use of Snoop spray should be discontinued and contact a medical specialist.

Children, during pregnancy and lactation

The use of the drug Snoop is contraindicated during pregnancy. The drug should be used with caution during breastfeeding.

Use in children

Contraindicated in children under the age of 6 years (for a 0.1% solution). In children under the age of 2 years, only a 0.05% solution of the drug should be used.

special instructions

Do not exceed the recommended period of use, including in chronic rhinitis. After opening the vial, the drug is suitable for use within 1 year. In therapeutic doses, xylometazoline does not cause disturbances in concentration or speed of psychomotor reactions.

drug interaction

Tricyclic antidepressants and medicines that inhibit monoamine oxidase cannot be used in conjunction with the drug.

Analogues of the drug Snoop

Xymelin Eco with menthol.
Galazolin.
Rhinorus.
Rinostop.
Influrin.
Grippostad Reno.
Rhinonorm.
Xylometazoline.
Nosolin.
Dr. Theiss Nazolin.
Pharmazolin.
Asterisk NOZ.
Nosolin balm.
Espazolin.
Xymelin.
Evkazolin Aqua.
Supreme NOZ.
Xylobene.
Sanorin Xylo.
Olint.
Rhinomaris.
Tizin Xylo Bio.
Tizin Xylo.
Brizolin.
For the nose.
Xylen.

Holiday conditions and price

The average cost of Snoop (nasal spray 15 ml) in Moscow is 110 rubles. Released without a prescription.

The shelf life of Snoop nasal spray is 5 years. It must be stored in undamaged original packaging, in a dark, dry place at an air temperature not exceeding +25 C. After the first opening of the bottle, the spray must be used within a period of time not exceeding 3 months. Keep away from children.

Post Views: 268

Snoop

Composition

1 g nasal spray Snoop 0.1% contains:
Xylometazoline hydrochloride - 1 mg;
Additional ingredients.

1 g nasal spray Snoop 0.05% contains:
Xylometazoline hydrochloride - 0.5 mg;
Additional ingredients.

pharmachologic effect

Snoop is a drug for intranasal use with a vasoconstrictor effect. Snoop contains xylometazoline hydrochloride, a substance of the alpha-adrenergic agonist group. Xylometazoline hydrochloride stimulates alpha-adrenergic receptors of the smooth muscle layer of the vessels of the nasal mucosa, resulting in vasoconstriction, a decrease in rhinorrhea, edema and hyperemia of the nasal mucosa and paranasal sinuses. Xylometazoline reduces the severity of symptoms of rhinitis of various etiologies, facilitates nasal breathing.
After a single application, the effect of the drug Snoop develops within 3-5 minutes and lasts up to 5 hours.
At topical application systemic absorption of xylometazoline is negligible.

Indications for use

Snoop is used for the symptomatic treatment of rhinitis in patients suffering from acute allergic rhinitis, sinusitis, hay fever and acute respiratory viral infections.
Snoop is also prescribed to patients suffering from eustachitis and otitis media.
Snoop can be recommended to reduce swelling and hyperemia of the nasal mucosa before rhinoscopy and other diagnostic procedures in the nasal passages.

Mode of application

Snoop is intended for intranasal use. Before the first use of the drug, it is recommended to press the sprayer several times to achieve the correct dosage of the spray. Before using the drug Snoop should clear the nasal passages of mucus. The dose of xylometazoline and the duration of therapy with Snoop is determined by the doctor.
Children 2 to 6 years of age are usually given 1 spray of Snoop 0.05% in each nasal passage.
Children over 6 years of age are usually prescribed xylometazoline at doses recommended for adults.

The maximum recommended daily dose of Snoop 0.05% is 3 sprays in each nasal passage.
Adults are usually prescribed 1 spray of Snoop 0.1% in each nasal passage up to 3 times a day.
The minimum recommended interval between doses of Snoop is 6 hours. Do not apply the spray more than 3 times a day.
The recommended duration of therapy is 3 to 7 days.

Side effects

Snoop is generally well tolerated by patients. In some cases, when using xylometazoline, the development of dryness of the nasal mucosa was noted.
With frequent and prolonged use of xylometazoline, patients may develop paresthesia, sneezing, increased secretory activity of the glands of the nasal mucosa, tachycardia, headache, vomiting, arrhythmias, arterial hypertension, sleep disturbances, insomnia and decreased visual acuity. In addition, with prolonged use of xylometazoline, the development of depressive conditions is possible.

Contraindications

Snoop is not used to treat patients with individual hypersensitivity to xylometazoline or additional ingredients of the drug.
Snoop should not be used for long-term therapy, in particular, xylometazoline is not prescribed for patients with chronic rhinitis of various etiologies.
Snoop is not prescribed to patients suffering from arterial hypertension, severe atherosclerosis, cardiac arrhythmias, glaucoma, thyrotoxicosis and atrophic rhinitis.
Xylometazoline is not recommended for patients who have undergone meningeal surgery.
In pediatric practice, the drug Snoop 0.05% is used only for the treatment of children older than 2 years, Snoop 0.1% - for the treatment of children older than 6 years.

Pregnancy

The use of the drug Snoop is contraindicated during pregnancy.
During lactation, the use of xylometazoline is allowed only after the issue of temporary interruption of breastfeeding has been resolved.

drug interaction

The combined use of the drug Snoop with monoamine oxidase inhibitors and tricyclic antidepressants is prohibited.

Overdose

When using excessive doses of xylometazoline, patients may experience irritation and dryness of the nasal and oral mucosa, as well as the development of paresthesia, tachycardia, arterial hypertension, vomiting, insomnia and visual impairment. With a chronic overdose of the drug Snoop, the development of depressive conditions is possible.
There is no specific antidote. With the development of symptoms of overdose, appropriate therapy is carried out. In case of an overdose of xylometazoline, the patient should be under medical supervision.

Release form

Nasal spray Snoop in polymer bottles with a sprayer of 15 ml (150 doses), in a cardboard box 1 bottle. Attention!
Description of the drug Snoop" on this page is a simplified and supplemented version of the official instructions for use. Before purchasing or using the drug, you should consult a doctor and read the annotation approved by the manufacturer.
Information about the drug is provided for informational purposes only and should not be used as a guide to self-medication. Only a doctor can decide on the appointment of the drug, as well as determine the dose and methods of its use.

In the treatment of rhinitis in adult patients, xylometazoline preparations, which include Snoop, are especially in demand. Such a drug acts quickly and permanently eliminates the uncomfortable symptoms of a runny nose. But is it allowed in childhood, how often can it be used in babies, and with what similar medicines can it be replaced?

Release form

Snoop is produced by Stada in only one form - a nasal spray. The medicine is white polyethylene bottles equipped with a special spray system. Inside one bottle is 15 ml of a clear liquid without any color, which corresponds to 150 doses of the drug.

Composition

The main component of Snoop, due to which the spray has a therapeutic effect, is called xylometazoline. It is contained in the preparation in the form of hydrochloride in two dosages, so the solution has a different concentration:

in a 0.05% spray per 1 milliliter of the product, there are 500 μg of xylometazoline;
A 0.1% preparation in each milliliter contains xylometazoline in an amount of 1 mg.

As an auxiliary component, 1 ml of any of the sprays contains 250 mg of sea water. In addition, the composition of the drug includes purified water and potassium dihydrogen phosphate.

A drug with a lower concentration is often called a children's Snoop, since it is used in childhood. Medicines can be distinguished primarily by their packaging - a box with a 0.05% solution is blue in color, and the numbers “0.05%” both on the box and on the bottle are highlighted in blue. A more concentrated medicine is sold in boxes with a red mark. The numbers "0.01%" both on the bottle and on the outer packaging are also highlighted in red.

Mechanism of action

Snoop belongs to a group of medicines called anticongestants or decongestants. Such medications have a vasoconstrictive and anti-edematous effect due to the effect on alpha-adrenergic receptors, which are located in the nasal mucosa. By stimulating such receptors, anticongestants cause a contraction of the lumen of blood vessels.

Xylometazoline in the composition of the spray has just such an effect, as a result of which the vessels in the nasopharynx narrow. This helps eliminate swelling of the mucosa or stop bleeding (if it started from small vessels in the nose), and also facilitates rhinoscopy and reduces the amount of discharge from the nose. The use of Snoop also has an anti-inflammatory effect and facilitates the process of breathing through the nose., because it helps to get rid of congestion and returns normal patency to the nasal passages.

It is important to note that the spray acts mainly locally. Its active ingredient can only be absorbed in very small amounts, such that modern methods cannot detect it in the bloodstream.

The effect of using Snoop can be noted just a few minutes after the solution enters the nasal passages. Its duration is up to 8-10 hours, which in most cases allows you to limit yourself to one or two times the use of the spray.

The presence of sea water in the solution contributes to the normalization of the function of the epithelium of the nasopharynx and has a positive effect on the secretion of goblet cells. This provides support for the physiological state of the inner surface of the nasal passages is normal.

Indications

In pediatrics, Snoop is most often used for acute respiratory diseases, which are manifested by a runny nose. In addition, the spray can prescribe:

children with acute rhinitis of an allergic nature;
small patients with sinusitis;
children diagnosed with hay fever;
a child with inflammation of the Eustachian tube;
to reduce mucosal edema in children with otitis media (as an addition to the main treatment of such a disease);
to perform any diagnostic procedures in the nose area, for example, to perform rhinoscopy.

From what age is it used in children?

The drug is contraindicated in children of the first two years of life. Children 2 years old can only be prescribed Snoop with a concentration of 0.05%. A more concentrated solution is used no earlier than six years. It is also important to note that the use of Snoop in childhood is recommended only as prescribed by a doctor and only during the period prescribed by the doctor.

Failure to comply with such conditions may worsen the condition of a small patient or provoke negative side effects of the spray.

Contraindications

Snoop treatment is prohibited:

with chronic rhinitis, in which the mucous membrane is atrophied;
with a rapid heart rate (tachycardia);
with glaucoma;
with an increase in blood pressure;
with hyperfunction of the thyroid gland;
with intolerance to xylometazoline or other ingredients of the spray;
if the child has ever undergone operations on the membranes of the brain.

If a small patient has diabetes mellitus, the use of the drug requires special care.

Snoop is not prescribed for adults when carrying a child, and while breastfeeding, the use of the medication, although allowed, should only be under medical supervision.

Side effects

The drug can cause severe dryness or irritation of the mucous membrane, as well as provoke sneezing, increased mucus production or a burning sensation. Such negative symptoms often appear when Snoop is used too often or the spray is used longer than the period prescribed by the doctor. In rare cases, after the injection of the drug, the mucous membrane of the nasopharynx swells, then an immediate consultation with a doctor is required to examine the child.

Snoop can also affect the nervous system of young patients if the dosage of the drug is high and the frequency of injections is more than the doctor prescribed or recommended in the annotation. In these cases, the child may complain of headaches and visual disturbances. In addition, the drug can provoke insomnia or cause depression.

In rare cases, during treatment with Snoop, a negative reaction to such a spray was recorded from the digestive tract (vomiting occurred in some patients) or the cardiovascular system (complaints of palpitations occurred, and the examination showed tachycardia, an increase in blood pressure or arrhythmia).

Instructions for use

Before each injection of the drug, the nasal passages must be cleared of excess secretions. To do this, it is recommended to use turundas made of cotton wool or a special aspirator. If the spray has not been used before (the bottle is sealed), then after opening its package, several clicks should be made on the rim of the sprayer so that a “fog” appears from the particles of the spray. After that, the medication will be ready for use.

When using Snoop, the bottle is held vertically with the spray device facing upwards (do not point it downwards or horizontally). After removing the protective cap and inserting the tip of the bottle into one nostril, you should press the sprayer and spray one dose of the drug into the nasal passage. Next, the process is repeated for the second nostril and the child is invited to inhale through the nose.

A single dose of Snoop for a patient of any age is one injection.

In the treatment of a child, it is important to use a solution concentration suitable for age:

if the baby is 2 years old, but not yet six years old, he is assigned a 0.05% spray;
for the treatment of children older than 6 years, a 0.1% preparation is used.

The frequency of injections of the drug is determined by the condition of the child. Often, it is enough to puff the medication 1 or 2 times a day. The maximum allowable frequency of Snoop's use is considered 3 times a day. More frequent use of the spray is prohibited.

The duration of treatment with Snoop should be short, due to the gradual addiction to its active ingredient. Doctors try to prescribe it to children at the lowest possible rate. For longer than 5-7 days, this medicine is not used.

One bottle should be used for one child. If the family has two or more children and the spray is prescribed to several patients, it is worth purchasing a separate medicine for each patient.

Overdose

In case of accidental overdose (for example, if a child of 4 or 5 years old injects 0.1% Snoop), a burning sensation in the nose, frequent sneezing, complaints of vision problems, increased nasal discharge, headaches, vomiting attacks and others may occur. negative reactions. In such a situation, the patient must be examined by a doctor., and to eliminate negative symptoms, symptomatic remedies prescribed by the doctor are used.

Compatibility with other medications

Like other vasoconstrictor drugs that affect alpha-adrenergic receptors, Snoop cannot be combined with certain groups of antidepressants - drugs that inhibit monoamine oxidase and tricyclic drugs. With other medicines that are prescribed for the treatment of rhinitis, sinusitis or otitis media (antibacterial drugs, antipyretics, and so on), Snoop is compatible.

Terms of sale

Snoop, like many of its counterparts, is sold without a prescription, so buying a spray does not cause any difficulties.

However, before you buy this medicine for a child, specialist advice is desirable.

The average price of one bottle of baby Snoop (0.05% solution) is 130-140 rubles, and for a 0.1% medicine you need to pay about 120 rubles.

Storage features

An unopened bottle of Snoop is good for 5 years from the date of manufacture. It is necessary to keep the medicine in a place where the temperature will not be higher than +25 degrees and the medicine will not be found by a small child. Since the solution placed inside the vial is sterile, and its composition does not include preservatives, after the first application, the shelf life is reduced to 3 months. If more time has passed since opening, but the solution still remains inside, it should be discarded.

Snoop is a vasoconstrictor spray with alpha-adrenomimetic activity for topical use in ENT practice. The active substance is Xylometazoline.

Composition of the drug (1 ml):

Xylometazoline hydrochloride - 0.5 mg or 1 mg;
Excipients: potassium dihydrogen phosphate, sea water, purified water.

The use of a spray in the nose of Snoop causes a narrowing of the blood vessels of the nasal mucosa, eliminating swelling and hyperemia of the nasal mucosa, restoring the patency of the nasal passages, and facilitating nasal breathing.

Sea water in the spray improves the function of the ciliated epithelium and normalizes the production of mucus in the goblet cells of the nasal mucosa, helping to maintain the natural physiological state of the nasal cavity.

The patency of the nasal passages is restored a few minutes after the use of the drug and persists for several hours.

Indications for use

What helps spray Snoop? According to the instructions, the drug is prescribed in the following cases:

Acute respiratory viral pathology, which occurs with inflammation of the nasal mucosa (rhinitis) and runny nose.
Acute allergic inflammation of the nasal mucosa ( allergic rhinitis).
Inflammation of the Eustachian tube (eustachitis).
Inflammatory process in the mucous membrane of the paranasal sinuses (sinusitis, frontal sinusitis).
Damage to the middle ear (acute otitis), the drug is intended as part of combination therapy.

Additionally, the spray is used to facilitate diagnostic procedures in the upper respiratory and nasal tract (rhinoscopy).

Instructions for use spray Snoop, dosage

The spray is applied intranasally (injected into the nose). To carry out the procedure, the nozzle is inserted into the nasal cavity, holding the bottle in a vertical position, press the rim once and take a light breath through the nose. After use, the bottle is closed with a protective cap.

For adults and children, the dosage regimen is the same - up to 3 times a day. Only the permissible concentration of the active substance differs.

0.05% solution: adults and children over 6 years old - 2 injections, children aged 2-6 years - from 1 to 2 injections;
0.1% solution: adults and children over 6 years old - 1 to 2 injections in each nasal passage.

Do not use the drug more than 3 times a day! The average duration of the course of therapy should not exceed 5-7 days.

The drug is addictive - do not exceed the dosage and duration of treatment!

Side effects

The instruction warns of the possibility of developing the following side effects when prescribing Snoop:

From the respiratory system: with frequent and / or prolonged use - irritation and / or dryness of the mucous membrane of the nasopharynx, burning, sneezing, hypersecretion; rarely - swelling of the nasal mucosa.
From the side of the central nervous system and peripheral nervous system: rarely - headache, insomnia, visual impairment, depression (with prolonged use in high doses), paresthesia.
From the side of the cardiovascular system: rarely - palpitations, tachycardia, arrhythmias, increased blood pressure.
From the respiratory system: rarely - vomiting.

Contraindications

It is contraindicated to prescribe Snoop spray in the following cases:

An increase in the level of arterial (arterial hypertension) pressure.
Severe atherosclerosis of the arteries, characterized by the deposition of cholesterol in their walls and a decrease in the diameter of the lumen.
A significant increase in the functional activity of the thyroid gland (thyrotoxicosis).
Glaucoma.
Atrophic rhinitis with severe thinning of the nasal mucosa.
Tachycardia.
Postponed surgical interventions on the meninges of the brain.
Pregnancy at any stage of the course.
The patient's age is up to 6 years (for a 0.1% solution) or up to 2 years (for a 0.05% solution).
Individual intolerance to the active substance or auxiliary components of the drug.

Assign with caution:

with coronary artery disease (angina pectoris),
prostatic hyperplasia,
thyrotoxicosis,
diabetes,
during lactation.

Overdose

Overdose can lead to serious disturbances in the work of the cardiac system (tachycardia, hypertension). Long-term treatment with high doses causes vomiting, paresthesia, dry mucous membranes, irritation of the nasal walls, visual disturbances, and insomnia.

Chronic overdose is characterized by a depressive state.

Treatment is symptomatic, there is no antidote.

Snoop spray analogues, price in pharmacies

If necessary, you can replace Snoop with an analogue of the active substance - these are drugs.